Brian Singerman, a partner at Founders Fund, has a knack for spotting promising startups. He invests in companies across various industries, with a focus on those that can significantly change their fields. Some of his successful bets include Affirm, Oscar Health, and Wish, which all had successful IPOs recently. He also has a good eye for acquisitions, having invested in Oculus (acquired by Facebook) and Postmates (acquired by Uber). Singerman started investing in early-stage startups while still working at Google and currently holds board positions in Solugen, Cloud9, and Emerald Therapeutics. He also led Founders Fund's investment in Stemcentrx, a biotech company acquired by AbbVie for a whopping $10 billion in 2016.